Abstract
Treatment of pediatric heterozygous familial hypercholesterolemia: Where do we stand in real-world study in France seven years after the recommendations of the european atherosclerosis society (EAS)?
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
